Abstract Number: PP02 • 2018 ACR/ARHP Annual Meeting
Sustained Weight Loss Managed by Multiple Medical Specialists
Background/Diagnosis: A patient who was diagnosed in 1974 with type 1 diabetes and in 2000 with rheumatoid arthritis weighed 366 pounds in 2014. He found…Abstract Number: PP03 • 2018 ACR/ARHP Annual Meeting
Managing OsteoArthritis Pain with Daily Meditation
Background/Diagnosis: Original diagnosis of OsteoArthritis in 2016 by family doctor (family medicine/general practitioner). There had been ongoing pain and symptoms for years. Original medications prescribed…Abstract Number: PP04 • 2018 ACR/ARHP Annual Meeting
Improved Quality of Life with Patient Engagement in Research
Background/Diagnosis: I am a woman, 60 years old who has lived with difficult-to-treat Rheumatoid Arthritis for 23 years. When first diagnosed with RA, there were…Abstract Number: PP05 • 2018 ACR/ARHP Annual Meeting
Integrative Approach to Treatment of an Adult with Juvenile Rheumatoid Arthritis
Background/Diagnosis: I was diagnosed in 1987 at age 3 with Polyarticular Juvenile Rheumatoid Arthritis which effected every joint in my body. At time of diagnosis…Abstract Number: PP06 • 2018 ACR/ARHP Annual Meeting
Learning to Self-Advocate in the Transition from Pediatric to Adult Lupus Care
Background/Diagnosis: I was diagnosed with lupus at age 15. I was starting my sophomore year of high school and noticed a rash that the doctor…Abstract Number: PP07 • 2018 ACR/ARHP Annual Meeting
Strengthening My Resiliency: How My Interprofessional Healthcare Team and I Improved My Management of Lupus
Background/Diagnosis: I was diagnosed with systemic lupus erythematosus (SLE) at the age of eleven and have experienced multiple SLE flares, hospitalizations, invasive procedures and complex…Abstract Number: PP08 • 2018 ACR/ARHP Annual Meeting
Communication, Support, and Advocacy Lead to Improved Health and Quality of Life
Background/Diagnosis: In 2007 I was diagnosed with Lupus which has since then wreaked havoc on my kidneys, lungs, GI tract, peripheral nervous system, to name…Abstract Number: PP09 • 2018 ACR/ARHP Annual Meeting
Improved Quality of Life and Decreased Symptoms of Lupus with Diet, Exercise, and Functional Medicine
Background/Diagnosis: Like most people who live with a chronic illness and/or autoimmune disease, my story started long before I realized. Symptoms came and went throughout…Abstract Number: PP10 • 2018 ACR/ARHP Annual Meeting
Using a Mobile App to Facilitate Patient-Doctor Discussions to Make Informed Decisions Regarding ‘Painsomnia’
Background/Diagnosis: As a patient with AS, Dawn founded #SpoonieChat to provide a space on twitter for people living with chronic diseases to support each other.…Abstract Number: PP11 • 2018 ACR/ARHP Annual Meeting
The Road Less Traveled– Nontraditional Approaches to Increased Patient Adherence and Positive Outcomes
Background/Diagnosis: African-American female diagnosed with SLE, Lupus Nephritis, Discoid Lupus, and Raynaud’s Phenomenon in 2011. Symptoms included joint pain, edema in the ankles, malar rash,…Abstract Number: PP12 • 2018 ACR/ARHP Annual Meeting
Living a Full Life with A.S. Through Adaptations
Background/Diagnosis: After running a half marathon and 2 5’ks, I had unexplained back/ hip pain that wouldn’t resolve. I returned to my PT. After 3…Abstract Number: PP13 • 2018 ACR/ARHP Annual Meeting
Support Groups and Patient Centred Care; Making a Difference in the Lives of People with Autoimmune and Rheumatic Conditions in Ghana
Background/Diagnosis: I felt relieved when my diagnosis was confirmed, but upon hearing Lupus and Nephritis and no cure, I felt shattered. I was referred to…Abstract Number: 1 • 2018 ACR/ARHP Annual Meeting
Profiling of B-Cell Related Factors and Its Decoy Receptors in Rheumatoid Arthritis: Potential Clues for Patient Stratification
Background/Purpose: B-cell over-activation plays a key role in the pathogenesis of rheumatoid arthritis (RA), thus being recognized as a therapeutic target. However, the activation of…Abstract Number: 2 • 2018 ACR/ARHP Annual Meeting
The Influence of Abatacept on Human B Cell Functions
Background/Purpose: Cytotoxic T lymphocyte antigen-4 (CTLA-4) competes with CD28 for binding the CD80/CD86 on antigen presenting cells to inhibit further activation of T cells. Abatacept,…Abstract Number: 3 • 2018 ACR/ARHP Annual Meeting
Interferon-Alpha Disrupts DNA-Specific B Cell Tolerance in 3H9 Mice
Background/Purpose: A central mediator of Systemic Lupus Erythematosus (SLE) pathogenesis is interferon-alpha (IFNα), which is elevated in the serum of SLE patients. IFNα has been…
ACR Meeting Abstracts